Business Details
8 Years
experience
Your Trusted Partner for Clinical Research Solutions
At Cns Network, our mission is to improve global human health by accelerating the development of life-changing therapies through exceptional medical research. Established with a vision to transform clinical trials, we operate 18 Centers of Excellence across the United States, each equipped with cutting-edge technology and staffed by board-certified physicians and research professionals. Our expertise spans complex early-phase central nervous system (CNS) trials, neurology, psychiatry, pain management, and specialized areas like psychedelics and sleep disorders. With over four decades of collective experience, our team has conducted thousands of studies, enrolling tens of thousands of patients, and consistently exceeding recruitment targets.We prioritize patient safety and engagement, leveraging standardized yet flexible processes to ensure high-quality data and regulatory compliance. Our integration of clinical expertise, advanced analytics, and a nationwide network enables sponsors and CROs to achieve faster timelines, reduced risks, and successful delivery of innovative treatments. As a founding member of the Association of Multisite Research Corporations (AMRC), we champion collaboration to streamline clinical research and enhance patient outcomes.
Services
Clinical Trials
CNS Research
Patient Recruitment
Early Phase Studies
Neurology Trials
Pain Management Studies
Psychedelics Research
Sleep Disorder Studies
Vaccine Trials
Dermatology Research
Details
- Year established: 2018
Highlights and features
- We offer 40+ years of expertise in complex early-phase CNS clinical trials.
- Our nationwide network of 18 Centers of Excellence ensures rapid patient recruitment.
- We implement standardized yet flexible processes for regulatory compliance and quality data.
- Our team includes internationally recognized key opinion leaders in CNS research.
- We exceed 100% of patient recruitment targets through precision targeting and outreach.
What people say
Efficient patient recruitment
Expert medical staff
High-quality study data
Nationwide network access
Regulatory compliance focus
Services
Clinical Trials
CenExel conducts high-quality clinical trials across diverse therapeutic areas, including CNS disorders, neurology, psychiatry, and vaccines. Our nationwide network of 18 Centers of Excellence ensures rapid patient recruitment and regulatory compliance. With over 40 years of expertise, we deliver actionable data to accelerate drug development and improve patient outcomes.
CNS Research
Specializing in central nervous system (CNS) research, CenExel leads complex early-phase trials for conditions like Alzheimers, Parkinsons, depression, and anxiety. Our team of key opinion leaders and board-certified physicians employs advanced biomarkers and translational research to optimize study design and regulatory approval pathways.
Patient Recruitment
CenExels in-house recruitment team uses precision targeting and culturally tailored outreach to exceed 100% of patient enrollment targets. Our strategies include strategic media placement, community engagement, and a database of diverse participants to ensure timely and successful trial completion.
Early Phase Studies
We specialize in early-phase clinical pharmacology studies, including first-in-human trials. Our 600+ inpatient beds and standardized protocols ensure rigorous data collection, while our biomarker-driven approach informs go/no-go decisions for pivotal trials and regulatory submissions.
Vaccine Trials
CenExels Vaccine Center of Excellence conducts trials for infectious diseases, biodefense, and pandemic preparedness. Our sites offer real-time quality control, PBMC isolation, and enrollment of participants aged 6 months to 85 years to support rapid immune response data collection.
People
Ryan Brooks
Chief Executive Officer and Executive Chairman of the Board
Ryan Brooks brings decades of healthcare leadership to CenExel, with prior roles at Abbott, Boston Scientific, and St. Jude Medical. He founded CenExel in 2018 after a successful career in clinical research site development and healthcare venture capital.
Steve Killian
Chief Financial Officer
Steve Killian leads CenExels financial strategy, leveraging expertise in operational finance and growth initiatives from prior roles at Alignment Healthcare and UnitedHealth Group.
Patrick McLaughlin
Chief Operating Officer
Patrick McLaughlin has 30 years of life sciences leadership, including founding Anaheim Clinical Trials. He drives CenExels operational efficiency and regulatory compliance across its 18 research sites.
Zach Mitchell
Chief Commercial Officer
Zach Mitchell oversees business development at CenExel, utilizing over a decade of clinical trial and project management experience to expand partnerships and optimize trial integration.
Larry Ereshefsky
Chief Scientific Officer, Early Phase
Dr. Larry Ereshefsky is a globally recognized leader in CNS research with 30+ years of experience designing early-phase trials. He guides CenExels translational research programs and regulatory strategies.
Questions
What therapeutic areas does CenExel specialize in?
CenExel specializes in CNS disorders, neurology, psychiatry, pain management, vaccines, dermatology, and women’s health, with expertise in early-phase trials.
How does CenExel ensure patient safety during clinical trials?
We implement rigorous screening, FDA-compliant protocols, and continuous staff training to maintain safety standards across all research sites.
Can I participate in a CenExel clinical trial remotely?
Most trials require in-person visits, but some studies may offer telehealth options. Check specific trial details for eligibility.
How long do CenExel clinical trials typically last?
Trial durations vary by phase and complexity, ranging from weeks for Phase I studies to years for long-term observational research.
What support does CenExel provide to sponsors?
We offer end-to-end support, including site selection, patient recruitment, data analytics, and regulatory guidance to streamline trial execution.
Are CenExel’s clinical trials accessible to diverse populations?
Yes, our recruitment strategies prioritize diversity, ensuring broad patient access to trials across urban and rural U.S. locations.
